LiveCell

LifeCell is a leader in the field of regenerative medicine, specializing in the development and commercialization of acellular tissue repair products. The company's flagship products, such as AlloDerm and Strattice, utilize a proprietary processing technology that removes cells from human or porcine tissue while preserving the essential biochemical and structural components of the extracellular matrix. These matrices serve as scaffolds for the body's own cells to repopulate and revascularize, facilitating natural tissue regeneration in complex surgical procedures. LifeCell's portfolio primarily serves the reconstructive, orthopedic, and urogynecological surgical markets, with a strong focus on breast reconstruction and abdominal wall repair. Following its acquisition by Allergan (now part of AbbVie), LifeCell continues to operate as a key division within the global aesthetics and surgical business.